3.26.1 html 293 391 2 true 60 0 false 10 false false R1.htm 1001 - Document - Cover Sheet http://www.inmedpharma.com/role/Cover Cover Cover 1 false false R2.htm 1002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.inmedpharma.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.inmedpharma.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 1004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.inmedpharma.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 1005 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Sheet http://www.inmedpharma.com/role/CondensedConsolidatedStatementsOfShareholdersEquityUnaudited Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 1006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.inmedpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 1007 - Disclosure - Corporate Information and Continuing Operations Sheet http://www.inmedpharma.com/role/CorporateInformationAndContinuingOperations Corporate Information and Continuing Operations Notes 7 false false R8.htm 1008 - Disclosure - Significant Accounting Policies Sheet http://www.inmedpharma.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Discontinued Operations Sheet http://www.inmedpharma.com/role/DiscontinuedOperations Discontinued Operations Notes 9 false false R10.htm 1010 - Disclosure - Inventories Sheet http://www.inmedpharma.com/role/Inventories Inventories Notes 10 false false R11.htm 1011 - Disclosure - Property, Equipment and Rou Assets, Net Sheet http://www.inmedpharma.com/role/PropertyEquipmentAndRouAssetsNet Property, Equipment and Rou Assets, Net Notes 11 false false R12.htm 1012 - Disclosure - Intangible Assets Sheet http://www.inmedpharma.com/role/IntangibleAssets Intangible Assets Notes 12 false false R13.htm 1013 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://www.inmedpharma.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 13 false false R14.htm 1014 - Disclosure - Share Capital and Reserves Sheet http://www.inmedpharma.com/role/ShareCapitalAndReserves Share Capital and Reserves Notes 14 false false R15.htm 1015 - Disclosure - Share-Based Payments Sheet http://www.inmedpharma.com/role/ShareBasedPayments Share-Based Payments Notes 15 false false R16.htm 1016 - Disclosure - Lease Obligations Sheet http://www.inmedpharma.com/role/LeaseObligations Lease Obligations Notes 16 false false R17.htm 1017 - Disclosure - Income Taxes Sheet http://www.inmedpharma.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 1018 - Disclosure - Segment Information Sheet http://www.inmedpharma.com/role/SegmentInformation Segment Information Notes 18 false false R19.htm 1019 - Disclosure - Commitments and Contingencies Sheet http://www.inmedpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 19 false false R20.htm 1020 - Disclosure - Related Party Transactions Sheet http://www.inmedpharma.com/role/RelatedPartyTransactions Related Party Transactions Notes 20 false false R21.htm 1021 - Disclosure - Subsequent Events Sheet http://www.inmedpharma.com/role/SubsequentEvents Subsequent Events Notes 21 false false R22.htm 1022 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.inmedpharma.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.inmedpharma.com/role/SignificantAccountingPolicies 22 false false R23.htm 1023 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.inmedpharma.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.inmedpharma.com/role/SignificantAccountingPolicies 23 false false R24.htm 1024 - Disclosure - Discontinued Operations (Tables) Sheet http://www.inmedpharma.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.inmedpharma.com/role/DiscontinuedOperations 24 false false R25.htm 1025 - Disclosure - Inventories (Tables) Sheet http://www.inmedpharma.com/role/InventoriesTables Inventories (Tables) Tables http://www.inmedpharma.com/role/Inventories 25 false false R26.htm 1026 - Disclosure - Property, Equipment and Rou Assets, Net (Tables) Sheet http://www.inmedpharma.com/role/PropertyEquipmentAndRouAssetsNetTables Property, Equipment and Rou Assets, Net (Tables) Tables http://www.inmedpharma.com/role/PropertyEquipmentAndRouAssetsNet 26 false false R27.htm 1027 - Disclosure - Intangible Assets (Tables) Sheet http://www.inmedpharma.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.inmedpharma.com/role/IntangibleAssets 27 false false R28.htm 1028 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://www.inmedpharma.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://www.inmedpharma.com/role/AccountsPayableAndAccruedLiabilities 28 false false R29.htm 1029 - Disclosure - Share Capital and Reserves (Tables) Sheet http://www.inmedpharma.com/role/ShareCapitalAndReservesTables Share Capital and Reserves (Tables) Tables http://www.inmedpharma.com/role/ShareCapitalAndReserves 29 false false R30.htm 1030 - Disclosure - Share-Based Payments (Tables) Sheet http://www.inmedpharma.com/role/ShareBasedPaymentsTables Share-Based Payments (Tables) Tables http://www.inmedpharma.com/role/ShareBasedPayments 30 false false R31.htm 1031 - Disclosure - Lease Obligations (Tables) Sheet http://www.inmedpharma.com/role/LeaseObligationsTables Lease Obligations (Tables) Tables http://www.inmedpharma.com/role/LeaseObligations 31 false false R32.htm 1032 - Disclosure - Income Taxes (Tables) Sheet http://www.inmedpharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.inmedpharma.com/role/IncomeTaxes 32 false false R33.htm 1033 - Disclosure - Segment Information (Tables) Sheet http://www.inmedpharma.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.inmedpharma.com/role/SegmentInformation 33 false false R34.htm 1034 - Disclosure - Corporate Information and Continuing Operations (Details) Sheet http://www.inmedpharma.com/role/CorporateInformationAndContinuingOperationsDetails Corporate Information and Continuing Operations (Details) Details http://www.inmedpharma.com/role/CorporateInformationAndContinuingOperations 34 false false R35.htm 1035 - Disclosure - Significant Accounting Policies - Schedule of Changes in Allowance for Expected Credit Losses For Trade Accounts Receivable (Details) Sheet http://www.inmedpharma.com/role/SignificantAccountingPoliciesScheduleOfChangesInAllowanceForExpectedCreditLossesForTradeAccountsReceivableDetails Significant Accounting Policies - Schedule of Changes in Allowance for Expected Credit Losses For Trade Accounts Receivable (Details) Details 35 false false R36.htm 1036 - Disclosure - Significant Accounting Policies - Schedule of Concentration of Customers (Details) Sheet http://www.inmedpharma.com/role/SignificantAccountingPoliciesScheduleOfConcentrationOfCustomersDetails Significant Accounting Policies - Schedule of Concentration of Customers (Details) Details 36 false false R37.htm 1037 - Disclosure - Significant Accounting Policies - Schedule of Number of Potential Common Shares (Details) Sheet http://www.inmedpharma.com/role/SignificantAccountingPoliciesScheduleOfNumberOfPotentialCommonSharesDetails Significant Accounting Policies - Schedule of Number of Potential Common Shares (Details) Details 37 false false R38.htm 1038 - Disclosure - Significant Accounting Policies Additional Information (Details) Sheet http://www.inmedpharma.com/role/SignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies Additional Information (Details) Details 38 false false R39.htm 1039 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations (Details) Sheet http://www.inmedpharma.com/role/DiscontinuedOperationsScheduleOfDiscontinuedOperationsDetails Discontinued Operations - Schedule of Discontinued Operations (Details) Details 39 false false R40.htm 1040 - Disclosure - Inventories (Details) Sheet http://www.inmedpharma.com/role/InventoriesDetails Inventories (Details) Details http://www.inmedpharma.com/role/InventoriesTables 40 false false R41.htm 1041 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://www.inmedpharma.com/role/InventoriesScheduleOfInventoriesDetails Inventories - Schedule of Inventories (Details) Details 41 false false R42.htm 1042 - Disclosure - Property, Equipment and Rou Assets, Net (Details) Sheet http://www.inmedpharma.com/role/PropertyEquipmentAndRouAssetsNetDetails Property, Equipment and Rou Assets, Net (Details) Details http://www.inmedpharma.com/role/PropertyEquipmentAndRouAssetsNetTables 42 false false R43.htm 1043 - Disclosure - Property, Equipment and Rou Assets, Net - Schedule of Property, Equipment and ROU Assets (Details) Sheet http://www.inmedpharma.com/role/PropertyEquipmentAndRouAssetsNetScheduleOfPropertyEquipmentAndRouAssetsDetails Property, Equipment and Rou Assets, Net - Schedule of Property, Equipment and ROU Assets (Details) Details 43 false false R44.htm 1044 - Disclosure - Intangible Assets (Details) Sheet http://www.inmedpharma.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://www.inmedpharma.com/role/IntangibleAssetsTables 44 false false R45.htm 1045 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details) Sheet http://www.inmedpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails Intangible Assets - Schedule of Intangible Assets (Details) Details 45 false false R46.htm 1046 - Disclosure - Intangible Assets - Schedule of Expects Amortization Expense (Details) Sheet http://www.inmedpharma.com/role/IntangibleAssetsScheduleOfExpectsAmortizationExpenseDetails Intangible Assets - Schedule of Expects Amortization Expense (Details) Details 46 false false R47.htm 1047 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://www.inmedpharma.com/role/AccountsPayableAndAccruedLiabilitiesScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) Details 47 false false R48.htm 1048 - Disclosure - Share Capital and Reserves (Details) Sheet http://www.inmedpharma.com/role/ShareCapitalAndReservesDetails Share Capital and Reserves (Details) Details http://www.inmedpharma.com/role/ShareCapitalAndReservesTables 48 false false R49.htm 1049 - Disclosure - Share Capital and Reserves - Schedule of Black-Scholes Model to Value the Modification of Warrants Issued (Details) Sheet http://www.inmedpharma.com/role/ShareCapitalAndReservesScheduleOfBlackScholesModelToValueTheModificationOfWarrantsIssuedDetails Share Capital and Reserves - Schedule of Black-Scholes Model to Value the Modification of Warrants Issued (Details) Details 49 false false R50.htm 1050 - Disclosure - Share Capital and Reserves - Schedule of Warrant Activity (Details) Sheet http://www.inmedpharma.com/role/ShareCapitalAndReservesScheduleOfWarrantActivityDetails Share Capital and Reserves - Schedule of Warrant Activity (Details) Details 50 false false R51.htm 1051 - Disclosure - Share-Based Payments (Details) Sheet http://www.inmedpharma.com/role/ShareBasedPaymentsDetails Share-Based Payments (Details) Details http://www.inmedpharma.com/role/ShareBasedPaymentsTables 51 false false R52.htm 1052 - Disclosure - Share-Based Payments - Schedule of Assumptions Used in the Black-Scholes Option Pricing Model (Details) Sheet http://www.inmedpharma.com/role/ShareBasedPaymentsScheduleOfAssumptionsUsedInTheBlackScholesOptionPricingModelDetails Share-Based Payments - Schedule of Assumptions Used in the Black-Scholes Option Pricing Model (Details) Details 52 false false R53.htm 1053 - Disclosure - Share-Based Payments - Schedule of Changes in Outstanding Options (Details) Sheet http://www.inmedpharma.com/role/ShareBasedPaymentsScheduleOfChangesInOutstandingOptionsDetails Share-Based Payments - Schedule of Changes in Outstanding Options (Details) Details 53 false false R54.htm 1054 - Disclosure - Lease Obligations (Details) Sheet http://www.inmedpharma.com/role/LeaseObligationsDetails Lease Obligations (Details) Details http://www.inmedpharma.com/role/LeaseObligationsTables 54 false false R55.htm 1055 - Disclosure - Lease Obligations - Schedule of Minimum Lease Payments (Details) Sheet http://www.inmedpharma.com/role/LeaseObligationsScheduleOfMinimumLeasePaymentsDetails Lease Obligations - Schedule of Minimum Lease Payments (Details) Details 55 false false R56.htm 1056 - Disclosure - Income Taxes - (Details) Sheet http://www.inmedpharma.com/role/IncomeTaxesDetails Income Taxes - (Details) Details http://www.inmedpharma.com/role/IncomeTaxesTables 56 false false R57.htm 1057 - Disclosure - Income Taxes - Schedule of Canadian Federal and Provincial Income Statutory Corporate Tax Rate (Details) Sheet http://www.inmedpharma.com/role/IncomeTaxesScheduleOfCanadianFederalAndProvincialIncomeStatutoryCorporateTaxRateDetails Income Taxes - Schedule of Canadian Federal and Provincial Income Statutory Corporate Tax Rate (Details) Details 57 false false R58.htm 1058 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://www.inmedpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Details 58 false false R59.htm 1059 - Disclosure - Segment Information (Details) Sheet http://www.inmedpharma.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.inmedpharma.com/role/SegmentInformationTables 59 false false R60.htm 1060 - Disclosure - Segment Information - Schedule of Reportable Segments (Details) Sheet http://www.inmedpharma.com/role/SegmentInformationScheduleOfReportableSegmentsDetails Segment Information - Schedule of Reportable Segments (Details) Details 60 false false R61.htm 1061 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.inmedpharma.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.inmedpharma.com/role/CommitmentsAndContingencies 61 false false R62.htm 1062 - Disclosure - Related Party Transactions (Details) Sheet http://www.inmedpharma.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.inmedpharma.com/role/RelatedPartyTransactions 62 false false R63.htm 1063 - Disclosure - Subsequent Events (Details) Sheet http://www.inmedpharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.inmedpharma.com/role/SubsequentEvents 63 false false R64.htm 995210 - Document - Submission Sheet http://xbrl.sec.gov/ffd/role/document/submissionTable Submission Cover 64 true false R65.htm 995211 - Document - Offerings Sheet http://xbrl.sec.gov/ffd/role/document/feesOfferingTable Offerings Cover 65 false false R66.htm 995215 - Document - Fees Summary Sheet http://xbrl.sec.gov/ffd/role/document/feesSummaryTable Fees Summary Cover 66 false false All Reports Book All Reports d131177ds4.htm inm-20250630.xsd d131177dexfilingfees.htm g131177g00r11.jpg g131177g00r14.jpg g131177g15n68.jpg g131177g22p79.jpg g131177g56a54.jpg g131177g56b54.jpg g131177g56b56.jpg g131177g56b58.jpg g131177g56b59.jpg g131177g56b60.jpg g131177g56b63.jpg g131177g56s52.jpg g131177g56s56.jpg g131177g56s57.jpg g131177g56s58.jpg g131177g56s59.jpg g131177g56s60.jpg g131177g56s61.jpg g131177g56s62.jpg g131177g56s63.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ffd/2026 false false